These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 11523283)

  • 41. Symposium on drug testing in the workplace. Committee on public health and the Section on Occupational Medicine, New York Academy of Medicine, February 3, 1988.
    Bull N Y Acad Med; 1989 Feb; 65(2):163-242. PubMed ID: 2611450
    [No Abstract]   [Full Text] [Related]  

  • 42. Enabling alcohol and drug abuse in the workplace.
    Nebr Nurse; 2009; 42(3):7. PubMed ID: 19771936
    [No Abstract]   [Full Text] [Related]  

  • 43. Antidrug and alcohol misuse prevention programs for personnel engaged in specified aviation activities. Final rule; technical amendment.
    Federal Aviation Administration (FAA), DOT
    Fed Regist; 2001 Nov; 66(223):57865-7. PubMed ID: 11776282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linking drug testing to treatment: an idea whose time has come.
    Thomas SP
    Issues Ment Health Nurs; 2010 Jun; 31(6):375. PubMed ID: 20450338
    [No Abstract]   [Full Text] [Related]  

  • 45. Effective drug-free workplace plan uses worker testing as a deterrent.
    Quazi MM
    Occup Health Saf; 1993 Jun; 62(6):26-7, 29-32. PubMed ID: 8327243
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral fluid collection: the neglected variable in oral fluid testing.
    Crouch DJ
    Forensic Sci Int; 2005 Jun; 150(2-3):165-73. PubMed ID: 15899565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do we have the training? The ethics of workplace drug testing and the GP.
    Evans A; Thornett A
    Aust Fam Physician; 2003 Aug; 32(8):645-7. PubMed ID: 12973876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of progressive cocaine abuse among adolescents.
    Fortuna JL
    Health Educ; 1983; 14(5):3-6. PubMed ID: 6443938
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of the occupational physician in substance abuse.
    Lambert SD
    Occup Med; 2002; 17(1):1-12, iii. PubMed ID: 11726332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testing employees.
    Hadfield L
    Drug Test Anal; 2009 Mar; 1(3):116-7. PubMed ID: 20355183
    [No Abstract]   [Full Text] [Related]  

  • 52. Legal issues facing physicians: substance abuse in the workplace.
    Clark HW; Johnson B
    Occup Med; 2002; 17(1):119-35, v. PubMed ID: 11726341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Special report. Drug testing in the workplace: an update.
    Hosp Secur Saf Manage; 1994 Oct; 15(6):5-9. PubMed ID: 10137771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Workplace substance abuse impairment: the occupational health care provider's role.
    McAndrew KG; McAndrew SJ
    AAOHN J; 2000 Jan; 48(1):32-45; quiz 46-7. PubMed ID: 15635918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adulterants and drugs-of- abuse testing: an update.
    Dasgupta A
    MLO Med Lab Obs; 2008 Feb; 40(2):24-5. PubMed ID: 18405221
    [No Abstract]   [Full Text] [Related]  

  • 56. Alcohol and drug testing ... balancing the interests of employers and employees.
    Monarch K
    Okla Nurse; 1995; 40(3):8-9. PubMed ID: 7566897
    [No Abstract]   [Full Text] [Related]  

  • 57. Case studies of drug testing in the workplace.
    Blume S; Cannella JM; Muir E; Stein P; Weihenmeyer E
    Bull N Y Acad Med; 1989 Feb; 65(2):215-42. PubMed ID: 2611457
    [No Abstract]   [Full Text] [Related]  

  • 58. Present and future opportunities.
    Kenney JE
    Occup Health Saf; 2005 Aug; 74(8):84, 86. PubMed ID: 16212029
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug and alcohol testing. DOT's, Part 40: Implications for employers.
    Eden T
    Occup Health Saf; 2000 Jul; 69(7):84-6, 88. PubMed ID: 10902123
    [No Abstract]   [Full Text] [Related]  

  • 60. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.